Publications by authors named "Anpei Hu"

Claim this Profile
D
Dual targeting of AMRC12 and disrupts MYC liquid condensates-driven nuclear pore complex biogenesis in neuroblastoma.
Anpei Hu, Chunhui Yang, Zhijie Wang, Xiaolin Wang, Xinyue Li, Shunchen Zhou

Theranostics· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity.
Xiaojing Wang, Yanhua Guo, Guo Chen, Erhu Fang, Jianqun Wang, Anpei Hu

Oncogene· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation.
Feng Yang, Anpei Hu, Dan Li, Jianqun Wang, Yanhua Guo, Kai Huang

Mol Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
Huajie Song, Dan Li, Xiaojing Wang, Erhu Fang, Feng Yang, Anpei Hu, Yanhua Guo, Kai Huang

J Hematol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity.
Anpei Hu, Guo Chen, Banghe Bao, Yanhua Guo, Dan Li

Clin Transl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15.
Feng Yang, Yangyang Liu, Jun Xiao, Bo Li, Yajun Chen, Anpei Hu, Hucheng Liu

Cell Prolif· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study.
Qilan Li, Jianqun Wang, Yang Cheng, Anpei Hu, Dan Li, Yanhua Guo

J Clin Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.
Wenjing Xiao, Jianqun Wang, Xiaojing Wang, Shuang Cai, Yanhua Guo, Anpei Hu

Autophagy· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robot-Assisted versus Trans-Umbilical Multiport Laparoscopic Ureteral Reimplantation for Pediatric Benign Distal Ureteral Stricture: Mid-Term Results at a Single Center.
Yanhua Guo, Yang Cheng, Dan Li, Hong Mei, Huan Jin, Anpei Hu

J Clin Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation.
Huajie Song, Jianqun Wang, Xiaojing Wang, Boling Yuan, Dan Li, Anpei Hu, Yanhua Guo, Shuang Cai

Oncogene· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of SPIB/SPI1-facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression.
Jianqun Wang, Xiaojing Wang, Yanhua Guo, Lin Ye, Dan Li, Anpei Hu, Shuang Cai

Clin Transl Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation.
Feng Yang, Anpei Hu, Yanhua Guo, Jianqun Wang, Dan Li, Shuang Cai

Mol Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
Erhu Fang, Xiaojing Wang, Jianqun Wang, Anpei Hu, Huajie Song, Yanhua Guo, Kai Huang

Theranostics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5.
Xiang Zhao, Dan Li, Feng Yang, Heng Lian, Jianqun Wang, Erhu Fang, Huajie Song, Anpei Hu, Yanhua Guo, Kai Huang

Mol Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
Huajie Song, Dan Li, Xiaojing Wang, Erhu Fang, Feng Yang, Anpei Hu, Yanhua Guo, Kai Huang

J Hematol Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Huanhuan Li, Feng Yang, Anpei Hu, Xiaojing Wang, Erhu Fang, Huajie Song, Yanhua Guo, Kai Huang

EMBO Mol Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation.
Feng Yang, Anpei Hu, Dan Li, Jianqun Wang, Yanhua Guo, Kai Huang

Mol Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of /PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression.
Erhu Fang, Xiaojing Wang, Feng Yang, Anpei Hu, Jianqun Wang, Huajie Song, Yanhua Guo, Kai Huang

Adv Sci (Weinh)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis